These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8876776)

  • 1. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Klauber MR; Schafer K; Woodbury P; Thomas R; Grundman M; Growdon J; Thal LJ
    Alzheimer Dis Assoc Disord; 1996; 10(3):132-40. PubMed ID: 8876776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Ernesto C; Thomas RG; Klauber MR; Schafer K; Grundman M; Woodbury P; Growdon J; Cotman CW; Pfeiffer E; Schneider LS; Thal LJ
    N Engl J Med; 1997 Apr; 336(17):1216-22. PubMed ID: 9110909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E for Alzheimer's disease and mild cognitive impairment.
    Isaac MG; Quinn R; Tabet N
    Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
    JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E for Alzheimer's disease.
    Tabet N; Birks J; Grimley Evans J
    Cochrane Database Syst Rev; 2000; (4):CD002854. PubMed ID: 11034775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selegiline and vitamin E in Alzheimer's disease.
    Adelman A
    J Fam Pract; 1997 Aug; 45(2):98-100. PubMed ID: 9267360
    [No Abstract]   [Full Text] [Related]  

  • 8. Selegiline in the treatment of behavioural disturbance in Alzheimer's disease.
    Lawlor BA; Aisen PS; Green C; Fine E; Schmeïdler J
    Int J Geriatr Psychiatry; 1997 Mar; 12(3):319-22. PubMed ID: 9152715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials.
    Coley N; Andrieu S; Jaros M; Weiner M; Cedarbaum J; Vellas B
    Alzheimers Dement; 2011 Nov; 7(6):602-610.e2. PubMed ID: 21745761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E and Alzheimer disease: the basis for additional clinical trials.
    Grundman M
    Am J Clin Nutr; 2000 Feb; 71(2):630S-636S. PubMed ID: 10681271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2000; (2):CD000442. PubMed ID: 10796544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-tocopherol and Alzheimer's disease.
    Pincus MM
    N Engl J Med; 1997 Aug; 337(8):572; author reply 573. PubMed ID: 9265106
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of longitudinal data in an Alzheimer's disease clinical trial.
    Thomas RG; Berg JD; Sano M; Thal L
    Stat Med; 2000 Jun 15-30; 19(11-12):1433-40. PubMed ID: 10844708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
    Siemers ER; Sundell KL; Carlson C; Case M; Sethuraman G; Liu-Seifert H; Dowsett SA; Pontecorvo MJ; Dean RA; Demattos R
    Alzheimers Dement; 2016 Feb; 12(2):110-120. PubMed ID: 26238576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interim report of the effect of selegiline (L-deprenyl) on the progression of disability in early Parkinson's disease. The Parkinson Study Group.
    Shoulson I
    Eur Neurol; 1992; 32 Suppl 1():46-53. PubMed ID: 1425820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
    Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
    Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-tocopherol and Alzheimer's disease.
    Kilander L; Ohrvall M
    N Engl J Med; 1997 Aug; 337(8):572-3. PubMed ID: 9265107
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term administration of selegiline for mild-to-moderate dementia of the Alzheimer's type.
    Tariot PN; Goldstein B; Podgorski CA; Cox C; Frambes N
    Am J Geriatr Psychiatry; 1998; 6(2):145-54. PubMed ID: 9581210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.